Intravitreal drug delivery systems for the treatment of ocular conditions
US11116776B2 · kind B2 · utility
1Cited by
4References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 12, 2019 |
| Grant date | Sep 14, 2021 |
| Priority date | — |
| Expiry date | Dec 12, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M31/002
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure teaches precisely engineered biodegradable drug delivery systems and methods of making and utilizing such systems. In aspects, the biodegradable drug delivery systems taught herein comprise intravitreal ocular implants suitable for delivery of corticosteroids to the posterior segment of a human eye. The intravitreal ocular implants described herein have a desired extended drug release profile suitable for treating inflammation of the human eye.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.